Initial report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japanese patients

By Emi Yasunori  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 254-259

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant chemotherapy in elderly patients (≥75 yr) completely resected for colon cancer stage III compared to younger patients: Toxicity and prognosis

By Jensen Søren   Vilmar Adam   Sørensen Jens  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 521-531

Humana Press, Inc

Access to resources Recommend Favorite

FOLFOX and FLOX Regimens for the Adjuvant Treatment of Resected Stage II and III Colon Cancer

By Sharif Saima   O'Connell Michael   Yothers Greg   Lopa Samia   Wolmark Norman  

Cancer Investigation, Vol. 26, Iss. 9, 2008-11 ,pp. : 956-963

Informa Healthcare

Access to resources Recommend Favorite

A Phase II Trial of Oxaliplatin, Folinic Acid, and 5-Fluorouracil (FOLFOX4) as First-Line Chemotherapy in Advanced Colorectal Cancer: A China Single-Center Experience

By Xu Nong   Fang Wei-Jia   Zhang Xiao-Chen   Yu Lan-Fang   Bao Han-Ying   Shi Gen-Ming   Huang Sui   Shen Peng  

Cancer Investigation, Vol. 25, Iss. 7, 2007-09 ,pp. : 599-605

Informa Healthcare

Access to resources Recommend Favorite

Multidrug resistance protein 2 genetic polymorphism and colorectal cancer recurrence in patients receiving adjuvant FOLFOX-4 chemotherapy

By            

Molecular Medicine Reports, Vol. 7, Iss. 2, 2013-01 ,pp. : 613-617

Spandidos Publications

Access to resources Recommend Favorite